• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Millennium Pharmaceuticals

Millennium Pharmaceuticals

  1. All
  2. 3rd Party
  3. Investing
  1. Takeda Licenses Rights to Use ImmunoGen, Inc.’s Novel Antibody-Drug Conjugate Technology

    Takeda Licenses Rights to Use ImmunoGen, Inc.’s Novel Antibody-Drug Conjugate Technology

  2. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.